Compare BTE & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTE | TWST |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 2004 | 2018 |
| Metric | BTE | TWST |
|---|---|---|
| Price | $4.13 | $47.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $46.25 |
| AVG Volume (30 Days) | ★ 24.9M | 1.0M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | N/A | $18.91 |
| Revenue Next Year | $7.93 | $15.07 |
| P/E Ratio | $18.43 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $1.44 | $23.30 |
| 52 Week High | $4.56 | $57.88 |
| Indicator | BTE | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 50.54 |
| Support Level | $3.90 | $41.85 |
| Resistance Level | $4.56 | $57.88 |
| Average True Range (ATR) | 0.19 | 2.84 |
| MACD | -0.04 | 0.25 |
| Stochastic Oscillator | 37.52 | 43.44 |
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.